HPV Vaccine Confers Multisite Protection
- PMID: 25904655
- DOI: 10.1158/2159-8290.CD-NB2015-060
HPV Vaccine Confers Multisite Protection
Abstract
Findings from a large multisite study show that the human papillomavirus vaccine can be effective in protecting women ages 18 to 25 against cervical, anal, and oral infections, even among those previously exposed to the virus.
©2015 American Association for Cancer Research.
Comment on
-
Multisite HPV16/18 Vaccine Efficacy Against Cervical, Anal, and Oral HPV Infection.J Natl Cancer Inst. 2015 Oct 14;108(1):djv302. doi: 10.1093/jnci/djv302. Print 2016 Jan. J Natl Cancer Inst. 2015. PMID: 26467666 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources